Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

EXTENDED PHENYTOIN SODIUM

PHENYTOIN SODIUM

Standard Dose
300MG EXTENDED
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview EXTENDED PHENYTOIN SODIUM is listed in Drugs@FDA under application 040731 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENYTOIN SODIUM Form and strength CAPSULE;ORAL - 300MG EXTENDED Sponsor SUN PHARM INDS Submission history Latest submission status date: 2023-03-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview EXTENDED PHENYTOIN SODIUM is listed in Drugs@FDA under application 040731 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENYTOIN SODIUM Form and strength CAPSULE;ORAL - 300MG EXTENDED Sponsor SUN PHARM INDS Submission history Latest submission status date: 2023-03-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
EXTENDED PHENYTOIN SODIUM (PHENYTOIN SODIUM) | Drug Monograph | MedicHelpline